Posts

Showing posts with the label Dermatology Prior Authorization

A Step-by-Step Guide to Auditing Pediatric Vaccine Administration Payments

Image
Vaccine administration is an important source of revenue for pediatric practices, but payment problems can easily go unnoticed when hundreds of vaccine claims are processed each month. Incorrect code selection, payer underpayments, missed administration charges, and claim denials can all reduce expected reimbursement. A regular audit can help pediatric groups identify these issues, recover missed revenue, and improve their billing process. Here is a step-by-step approach to auditing pediatric vaccine administration payments. Step 1: Review the Vaccine Administration Codes Start by reviewing the administration codes reported on vaccine claims. Pediatric practices commonly use codes such as 90460 and 90471 , but these codes have different reporting requirements. The billing team should verify that the administration code matches the service actually provided and that the documentation supports the code reported. For a detailed comparison, review Vaccine Admin Codes 90460 vs. 90471 in Ped...

Are Dermatology Prior Authorization Delays Slowing Down Reimbursements in 2026?

Image
Yes, dermatology prior authorization delays are increasingly slowing down reimbursements in 2026 as payers expand utilization review policies for high-cost dermatologic treatments and procedures. Many dermatology practices are experiencing longer approval timelines, stricter documentation requirements, and higher administrative workloads before services can even be billed. Prior authorizations are designed to ensure medical necessity, but in dermatology—where biologics, specialty medications, and advanced treatments are common—the process has become more complex. As a result, delays at the authorization stage are now one of the leading contributors to reimbursement slowdowns. Why Prior Authorizations Are Increasing in Dermatology Several industry changes are contributing to the rise in dermatology prior authorization delays . Payers are expanding review requirements for treatments that involve: Biologic therapies for psoriasis and eczema Advanced dermatologic procedures High-...